Politiparty
Politiparty

118th Congress Health

S. 1250: Drug-price Transparency for Consumers Act of 2023

Introduced

  1. Introduced (completed)Apr 20, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Apr 20, 2023

Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023

This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

8

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Richard Durbin D-IL SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Richard Durbin

History

  1. Apr 20, 2023Introduced in the Senate by Richard Durbin.
Show the full action history (2 actions)
  1. Apr 20, 2023Introduced in Senate
  2. Apr 20, 2023Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)